References
- Alanazi F, Li H, Halpern DS, et al. (2003). Synthesis, preformulation and liposomal formulation of cholesteryl carborane esters with various fatty chains. Int J Pharm 255:189–97
- Barth RF. (2003). A critical assessment of boron neutron capture therapy: an overview. J Neurooncol 62:1–5
- Barth RF, Coderre JA, Vicente MGH, Blue TE. (2005). Boron neutron capture therapy of cancer: current status and future prospects. Clin Cancer Res 11:3987–4002
- Bregadze VI, Sivaev IB, Glazun SA. (2006). Polyhedral boron compounds as potential diagnostic and therapeutic antitumor agents. Anticancer Agents Med Chem 6:75–109
- Heyes JA, Niculescu-Duvaz D, Cooper RG, Springer CJ. (2002). Synthesis of novel cationic lipids: effect of structural modification on the efficiency of gene transfer. J Med Chem 45:99–114
- Hidalgo FJ, Nogales F, Zamora R. (2004). Determination of pyrrolized phospholipids in oxidized phospholipid vesicles and lipoproteins. Anal Biochem 334:155–63
- Hiratsuka J, Yoshino K, Kondoh H, et al. (2000). Biodistribution of boron concentration on melanoma-bearing hamsters after administration of p-, m-, o-boronophenylalanine. Jpn J Cancer Res 91:446–50
- Ji B, Peacock G, Lu DR. (2002). Synthesis of cholesterol--carborane conjugate for targeted drug delivery. Bioorg Med Chem Lett 12:2455–8
- Kader A, Davis PJ, Kara M, Liu H. (1998). Drug targeting using low-density lipoprotein (LDL): physicochemical factors affecting drug loading into LDL particles. J Control Rel 55:231–43
- Kamidate T, Suita T, Watanabe H. (1996). Assay of phosphatidylcholine in liposome suspensions by inductively coupled plasma atomic emission spectrometry with ultrasonic nebulizer. Anal Biochem 241:264–6
- Li F, Goessler W, Irgolic KJ. (1999). Determination of selenium compounds by HPLC with ICP-MS or FAAS as selenium-specific detector. Se Pu 17:240–4
- Liu J, Kraut E, Bender J, et al. (2002). Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients. Cancer Chemother Pharmacol 49:367–74
- Meidan VM, Cohen JS, Amariglio N, et al. (2000). Interaction of oligonucleotides with cationic lipids: the relationship between electrostatics, hydration and state of aggregation. Biochim Biophys Acta 1464:251–61
- Morrison DE, Issa F, Bhadbhade M, et al. (2010). Boronated phosphonium salts containing arylboronic acid, closo-carborane, or nido-carborane: synthesis, X-ray diffraction, in vitro cytotoxicity and cellular uptake. J Biol Inorg Chem 15:1305–18
- Shawer M, Greenspan P, Oie S, Lu DR. (2002). VLDL-resembling phospholipid-submicron emulsion for cholesterol-based drug targeting. J Pharm Sci 91:1405–13
- Suita T, Kamidate T. (1999). Preparation of antibody-coupled liposomes containing horseradish peroxidase as a marker molecule. Anal Sci 15:349–52
- Svantesson E, Capala J, Markides KE, Pettersson J. (2002). Determination of boron-containing compounds in urine and blood plasma from boron neutron capture therapy patients: the importance of using coupled techniques. Anal Chem 74:5358–63
- Valliant JF, Guenther KJ, King AS, et al. (2002). The medicinal chemistry of carboranes. Coord Chem Rev 232:173–230
- Versluis AJ, Rump ET, Rensen PC, et al. (1999). Stable incorporation of a lipophilic daunorubicin prodrug into apolipoprotein E-exposing liposomes induces uptake of prodrug via low-density lipoprotein receptor in vivo. J Pharmacol Exp Ther 289:1–7
- Wasan KM, Brazeau GA, Keyhani A, et al. (1993). Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins. Antimicrob Agents Chemother 37:246–50
- Wasan KM, Ramasway M, Cassidy SM, et al. (1997). Physical characteristics and lipoprotein distribution of liposomal nystatin in human plasma. Antimicrob Agents Chemother 41:1871–5
- Zheng J, Shibata Y, Tanaka A. (2002). Study of the stability of selenium compounds in human urine and determination by mixed ion-pair reversed-phase chromatography with ICPMS detection. Anal Bioanal Chem 374:348–53